Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$874K Sell
55,021
-12,709
-19% -$197K 0.02% 351
2026
Q1
$915K Sell
67,730
-11,794
-15% -$165K 0.02% 342
2025
Q4
$990K Buy
79,524
+8,323
+12% +$89.8K 0.03% 326
2025
Q3
$705K Buy
71,201
+12,957
+22% +$126K 0.02% 355
2025
Q2
$521K Buy
+58,244
New +$492K 0.02% 336

Other funds holding VTRS

CSM Advisors's VTRS Position: Q2 2026 in Review

CSM Advisors reduced its Viatris (VTRS) stake by 19% in Q2 2026, selling an estimated $197K and leaving 55,021 shares worth $874K. The position accounts for 0.02% of the portfolio, ranked #351.

CSM Advisors first reported a position in VTRS in Q2 2025 and has held it in 5 quarters since. The position peaked at $990K in Q4 2025. 1,026 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • CSM Advisors held 55,021 shares of Viatris worth $874K as of Q2 2026.
  • CSM Advisors sold 12,709 Viatris shares in Q2 2026, an estimated $197K.
  • Viatris made up 0.02% of CSM Advisors's portfolio in Q2 2026, its #351 holding.
  • CSM Advisors first reported a position in Viatris in Q2 2025 and has held it in 5 quarters since.
  • CSM Advisors's Viatris position peaked at $990K in Q4 2025.
  • 1,026 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on CSM Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.